649 studies found for:    Open Studies | "Liver Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy
Conditions: Hepatoma;   Cinobufacin Injection
Intervention: Drug: Cinobufacin injection
22 Unknown  Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Condition: Hepatocellular Cancer
Intervention: Drug: [Met5]-enkephalin (Infusion of opioid growth factor )
23 Recruiting Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours
Condition: Liver Tumour
Intervention: Drug: lyso-thermosensitive liposomal (LTSL) doxorubicin
24 Recruiting Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer
Condition: Liver Cancer
Interventions: Biological: DC-CIK cells;   Biological: γδ T cells;   Biological: γδ T/DC-CIK cells
25 Unknown  Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Condition: Liver Tumors
Intervention: Radiation: Stereotactic Body Radiation Therapy
26 Recruiting A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms
Condition: Liver Neoplasms
Interventions: Other: contrast-enhanced ultrasound guided biopsy;   Other: conventional ultrasound guided biopsy;   Device: Ultrasound
27 Recruiting Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE
Condition: Advanced Adult Primary Liver Cancer
Intervention: Drug: Oxaliplatin and fluorouracil
28 Recruiting 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC)
Interventions: Device: 3 Tesla Magnetic Resonance Imaging;   Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)
29 Unknown  HAI Via Interventionally Implanted Port Catheter Systems
Conditions: Colorectal Cancer;   Liver Neoplasms;   Hepatocellular Carcinoma;   Gallbladder Cancer;   Bile Duct Cancer
Intervention: Device: interventionally implanted hepatic arterial port catheter
30 Recruiting Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Fluoromethylcholine (FCH) PET/CT Imaging
31 Recruiting Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer
Condition: Liver Cancer
Interventions: Drug: whole liver lobe cTACE doxorubicin;   Drug: superselective cTACE doxorubicin
32 Recruiting Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Condition: Liver Cancer
Intervention: Device: Irreversible electroporation (IRE)
33 Recruiting Assessment of Frailty in Patients With Advanced Hepatocellular Cancers
Condition: Hepatocellular Cancer
Intervention:
34 Recruiting Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Radiation: yttrium Y 90 glass microspheres;   Other: laboratory biomarker analysis
35 Recruiting Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta
Condition: Liver Cancer
Intervention: Other: Aflatoxin
36 Recruiting NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Radiation: NBTXR3, IL or IA injection + SBRT
37 Unknown  Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)
Condition: Liver Cancer
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
38 Recruiting Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis
39 Recruiting PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Stage D Adult Primary Liver Cancer (BCLC);   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: PET scan;   Procedure: CT Scan;   Procedure: hepatic artery embolization
40 Recruiting First-in-Human Safety and Tolerability Study of MTL-CEBPA in Patients With Advanced Liver Cancer
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Drug: MTL-CEBPA

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years